CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
27.01 31.09 56.28 188.48

+8 more quarters

P/S ratio
0.32 0.22 0.25 0.24
P/FCF ratio
11.25 12.37 12.88 15.20
P/Operating CF
20.85 21.52 29.66 120.19
P/B ratio
1.66 1.18 1.33 1.31
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.43 0.35 0.38 0.38
EV/EBITDA
9.70 8.78 10.31 9.86
EV/Operating CF
12.16 13.81 14.52 16.50
EV/FCF
15.29 19.30 19.79 23.88
Quick Ratio
0.62 0.61 0.57 0.59
Current Ratio
0.87 0.87 0.84 0.83
Net Debt/EBITDA
8.14 8.85 16.56 14.95
Debt/Assets
24.20% 24.95% 25.47% 25.78%
Debt/Equity
0.77 0.81 0.86 0.90
Asset Turnover
1.62 1.60 1.59 1.55
Operating CF/Net income
2.13 1.44 1.15 (0.20)
Capex/Depreciation
(0.61) (0.76) (0.68) (0.10)
Interest Coverage
6.21 6.05 2.68 (4.09)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.43 0.44 0.44 0.44
Share Based Compensation of Revenue
0.17% 0.26% 0.13% 0.13%
Graham Net Nets
(0.74) (1.10) (1.03) (1.10)
Graham Number
73.37 56.30 43.45 22.77
Earnings Yield
3.70% 3.22% 1.78% 0.53%
Free Cash Flow Yield
8.89% 8.09% 7.76% 6.58%
Revenue per Share
82.95 78.89 83.42 81.06
Operating CF per Share
4.96 3.34 2.68 0.63
Capex per Share
(0.54) (0.67) (0.62) (0.55)
Free Cash Flow per Share
4.42 2.67 2.06 0.08
Cash per Share
10.91 9.27 8.36 8.85
Shareholders Equity per Share
62.47 60.99 59.50 57.61
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
62.47 60.99 59.50 57.61
Free Cash Flow
5,654.00 3,400.00 2,606.00 98.00
Working Capital
(11,695.00) (11,589.00) (13,978.00) (15,586.00)
Capital Expenditures
(691.00) (849.00) (784.00) (698.00)
Net Current Asset Value
(98,523.00) (100,520.00) (103,442.00) (105,108.00)
EV/EBIT
21.69 23.92 33.16 30.57
Capex to Sales
0.01 0.01 0.01 0.01
Price to Operating Income
15.96 15.32 21.58 19.46
Other line items
Average Receivables
40,480.00 40,308.50 38,124.00 40,018.00
Average Payables
17,212.50 16,728.00 16,766.50 16,738.50
Average Inventory
17,534.50 17,577.50 18,676.50 18,305.50
Average Assets
256,055.50 254,279.50 253,376.50 253,877.00
Average Common Equity
78,725.00 77,373.50 75,556.00 74,108.00

Fold the line items

Columns are period end dates